Bibliographic detailsTopotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for advanced ovarian cancer (for relapsed disease only) (Review TA91 & TA222) (ID468). Health Technology Assessment
StatusThis is a bibliographic record of an ongoing health technology assessment being undertaken by a member of INAHTA. Links to the published report and any other relevant documentation will be added when available.
Indexing statusSubject indexing assigned by CRD
Index termsAntibiotics, Antineoplastic; Doxorubicin; Humans; Ovarian Neoplasms; Paclitaxel; Recurrence; Topotecan